← Back to Search

Robotics

Sensory-Motor Rehabilitation for Stroke

N/A
Recruiting
Led By Li-Qun Zhang, Ph.D.
Research Sponsored by University of Maryland, Baltimore
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 18-80
Ankle impairments
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at the beginning and end of 3-week training, and 1 month after the treatment ends
Awards & highlights

Study Summary

This trial will test whether an intensive motor-sensory rehabilitation using a wearable robot can help patients with acute stroke recover sensorimotor function, reduce ankle impairments, and improve balance and gait.

Who is the study for?
This trial is for stroke survivors aged 18-80 with ankle impairments and hemiplegia or hemiparesis. It's suitable for those who've had their first unilateral acute stroke, either hemorrhagic or ischemic, from 24 hours to a year post-stroke. Excluded are individuals with mild/no impairment, severe cardiovascular issues, cognitive impairments preventing instruction following, unstable medical conditions, leg ulcers/wounds below the knee, or severe leg pain.Check my eligibility
What is being tested?
The study tests an intensive motor-sensory rehabilitation using a wearable robot on patients after a stroke. The goal is to aid sensorimotor recovery and improve balance and walking by reducing ankle impairments. Participants will be randomly assigned to either the Study group receiving therapy or Control group.See study design
What are the potential side effects?
While not explicitly stated in this summary, potential side effects may include muscle soreness due to stretching and movement exercises as well as skin irritation from wearing the rehabilitation robot.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 80 years old.
Select...
I have issues with my ankle.
Select...
I have weakness or paralysis on one side of my body.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at the beginning and end of 3-week training, and 1 month after the treatment ends
This trial's timeline: 3 weeks for screening, Varies for treatment, and at the beginning and end of 3-week training, and 1 month after the treatment ends for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Changes of Fugl-Meyer Lower Extremity (FMLE)
Secondary outcome measures
Changes of 10 meter Walk Test
Changes of Berg Balance Scale
Changes of Modified Ashworth Scale (MAS)
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Study groupExperimental Treatment1 Intervention
Subjects in the Study group will receive stretching and active movement training with robotic guidance and intelligent control
Group II: Control groupExperimental Treatment1 Intervention
Subjects in the Control group will receive stretching and active movement training without robotic guidance.

Find a Location

Who is running the clinical trial?

Northwestern UniversityOTHER
1,589 Previous Clinical Trials
916,986 Total Patients Enrolled
30 Trials studying Stroke
25,065 Patients Enrolled for Stroke
Northwestern Memorial HospitalOTHER
40 Previous Clinical Trials
16,576 Total Patients Enrolled
University of Maryland, BaltimoreLead Sponsor
688 Previous Clinical Trials
374,516 Total Patients Enrolled
10 Trials studying Stroke
1,331 Patients Enrolled for Stroke

Media Library

Stretching and Active Movement Training (Robotics) Clinical Trial Eligibility Overview. Trial Name: NCT02369770 — N/A
Stretching and Active Movement Training (Robotics) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02369770 — N/A
Stroke Research Study Groups: Study group, Control group
Stroke Clinical Trial 2023: Stretching and Active Movement Training Highlights & Side Effects. Trial Name: NCT02369770 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Am I eligible to join this research project?

"This clinical trial seeks to enrol 140 stroke sufferers aged 18-80. Additionally, potential participants must have had a unilateral acute stroke within 24 hours of hospital admission and up until one year post-stroke; they must also display hemiplegia or hemiparesis as well as impairment in their ankles."

Answered by AI

Does this research accept older volunteers?

"This trial necessitates that participants are aged 18 to 80. If a patient is under the age of consent, 37 studies may be available while 1007 trials exist for those over 65."

Answered by AI

Is enrollment into this research endeavor still open?

"Clinicaltrials.gov affirms that this medical trial is currently attempting to enrol participants and was first posted on April 26th 2019, with the last alteration taking place on March 17th 2022."

Answered by AI

How many individuals are being included in this research project?

"Affirmative. As per the clinicaltrials.gov website, this medical trial is presently recruiting patients who meet its inclusion criteria and have been approved by their physician. It was initially published on April 26th 2019, with recent changes made on March 17th 2022, and aims to enrol 140 participants from a sole location."

Answered by AI
~35 spots leftby Dec 2025